Alejandro Turek
Buenos Aires,C
Summary
Dedicated and experienced medical director with over 28 years in the healthcare industry. Demonstrated leadership, expertise in patient care, and extensive experience fostering academic dialogue and collaboration with key opinion leaders and healthcare teams. Skilled in facilitating safe administration of new cancer drugs in Oncology, Hematology, and orphan drugs in Rare Diseases to advance patient outcomes. Effective collaborator within interdisciplinary groups, and adept at strategic planning and training programs that enhance staff proficiency and operational efficiency. Provided medical support for day ambulatory hospital and inpatient infusion therapies, ensuring strict compliance with regulatory standards. Known for innovative clinical program development, leading to increased sales across all product lines. Consistently achieved 120% of recruitment objectives for Oncology-Hematology therapies. Experienced mentor for medical managers and clinical science agents, with a commitment to ongoing medical education. Extended high performance in medical assistance from 1984 in Oncology (public and unions) and cancer cost control for different payors from 1999 (unions).
Overview
28
28
years of professional experience
Work History
Chief of Oncology
Sanatorio San José
01.2006 - Current
- Self-motivated, with a strong sense of personal responsibility.
- Worked effectively in fast-paced environments.
- Skilled at working independently and collaboratively in a team environment.
- Proven ability to learn quickly and adapt to new situations.
- Excellent communication skills, both verbal and written.
- Assisted with day-to-day operations, working efficiently and productively with all team members.
- Organized and detail-oriented with a strong work ethic.
- Used critical thinking to break down problems, evaluate solutions, and make decisions.
Independent External Consultant for Oncology
01.2025 - 01.2026
- Focused on new drugs and competitors in breast, lung, colorectal, ovarian cancer, and multiple myeloma. Expertise in pharmaco-economics. Freelance.
Senior Medical Director
Biofactor S.A. Argentina
11.2021 - 03.2024
- Part-time, hybrid role.
- (Hematology; Kedrion licenses)
Medical Head Argentina
myTomorrows
09.2016 - 09.2017
- Part-time, remote position.
- (Early Access, Hematology)
Southern Cone Medical Director
Genzyme
01.2011 - 03.2015
- Led Medical Affairs Department, including Regulatory, Pharmacovigilance, and risk minimization plans. Supported business units in Rare Diseases (Gaucher, Fabry, Pompe, MPS I), Endocrinology, Cardio-metabolics, Multiple Sclerosis, and managed Genzyme clinical trials (phases I-IV). Developed internal and external medical education programs and patient support initiatives in Oncology, Hematology, and Rare Diseases. Launched Clolar, Lemtrada, and Mozobil.
Sales & Marketing Manager Hematology-Oncology
Genzyme Argentina
12.2008 - 12.2011
- Responsible for pediatric acute leukemia, hemo transplant, adult chronic leukemia, and aplastic anemia.
Medical Director
Serono Group-Filaxis Argentina-Fresenius Kabi
04.1998 - 11.2008
- Oversaw Oncology, Hematology, Urology, AIDS, and Nutritional Oncology lines. Consultant for External Commerce. Managed bioequivalence clinical trials for antiretrovirals; pharmacovigilance. Launched Oncaspar, Pacis, and 62 product copies in various therapeutic
Education
M.D. - Clinical Investigation
Angel Roffo INstitute
Buenos Aires05-1989
Clinical Oncology
Buenos Aires University
01-1989
M.D. - Clinical Investigation
Angel Roffo INstitute
Buenos Aires05-1989
Internal Medicine, Oncology
U.B.A., Kennedy University, Maimonides University
Bone Marrow Transplantation Unit
Morton Plant Hospital
01-1995
Skills
- Friendly, positive attitude
- Teamwork and collaboration
- Customer service
- Problem-solving
- Expert level: Oncology; Clinical Trials; Pharmacovigillance; Regulatory; Strategis planning; Leadership; Market Access
Affiliations
Ex titular member of AAOC (Argentina), ASCO and ASH (USA)
Publications
70 papers; co-author in 2 books about cancer and cancer pain
Comprehensive management in Oncology, second opinion audit in high-cost therapeutics
OSCHOCA – OSSIMRA – OSAPM - OSDOP- OSFE – OSPEDYC – OSPRERA-OSCE-OSPM-OSEIV (national level) 1999-2026. IPS Misiones - OSEP Catamarca- MSAL Santiago del Estero 2024-present.
Languages
English
Full Professional
Spanish
Native or Bilingual
Timeline
Independent External Consultant for Oncology
01.2025 - 01.2026
Senior Medical Director
Biofactor S.A. Argentina
11.2021 - 03.2024
Medical Head Argentina
myTomorrows
09.2016 - 09.2017
Southern Cone Medical Director
Genzyme
01.2011 - 03.2015
Sales & Marketing Manager Hematology-Oncology
Genzyme Argentina
12.2008 - 12.2011
Chief of Oncology
Sanatorio San José
01.2006 - Current
Medical Director
Serono Group-Filaxis Argentina-Fresenius Kabi
04.1998 - 11.2008
Clinical Oncology
Buenos Aires University
Internal Medicine, Oncology
U.B.A., Kennedy University, Maimonides University
Bone Marrow Transplantation Unit
Morton Plant Hospital
M.D. - Clinical Investigation
Angel Roffo INstitute
M.D. - Clinical Investigation
Angel Roffo INstitute